Cargando…

Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma

BACKGROUND: Lung adenocarcinoma (LUAD), the major lung cancer histotype, represents 40% lung cancers. Currently, outcomes are remarkably different in LUAD patients with similar AJCC/UICC-TNM features. T cell proliferation-related regulator genes (TPRGs) relate to the proliferation, activity and func...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Qin, Zhu, Weiyuan, Gong, Han
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106713/ https://www.ncbi.nlm.nih.gov/pubmed/37077919 http://dx.doi.org/10.3389/fimmu.2023.1148483

Ejemplares similares

Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

Deep learning for predicting subtype classification and survival of lung adenocarcinoma on computed tomography
por: Wang, Chengdi, et al.
Publicado: (2021)

Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma
por: Qiu, Chenjie, et al.
Publicado: (2021)

Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Shang, Shipeng, et al.
Publicado: (2022)

A TP53 Related Immune Prognostic Model for the Prediction of Clinical Outcomes and Therapeutic Responses in Lung Adenocarcinoma
por: Zhang, Xiaonan, et al.
Publicado: (2022)

Development of a copper metabolism-related gene signature in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2022)

Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma
por: Zeng, Weibiao, et al.
Publicado: (2023)

Subtype Classification, Immune Infiltration, and Prognosis Analysis of Lung Adenocarcinoma Based on Pyroptosis-Related Genes
por: Liu, Qi, et al.
Publicado: (2022)

Characterization of m(6)A RNA Methylation Regulators Predicts Survival and Immunotherapy in Lung Adenocarcinoma
por: Zhu, Minggao, et al.
Publicado: (2021)

Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
por: Wang, Yang, et al.
Publicado: (2021)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
por: Wang, Qi, et al.
Publicado: (2023)

A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer
por: Dong, Bingqi, et al.
Publicado: (2023)

A novel zinc metabolism-related gene signature to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Chang, Wuguang, et al.
Publicado: (2023)

RASGRP2 is a potential immune-related biomarker and regulates mitochondrial-dependent apoptosis in lung adenocarcinoma
por: Liu, Yongting, et al.
Publicado: (2023)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
por: Koh, Young Wha, et al.
Publicado: (2023)

Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma
por: Zhou, Renlong, et al.
Publicado: (2022)

Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction
por: Hu, Xin, et al.
Publicado: (2021)

Immunotherapy efficacy predictive tool for lung adenocarcinoma based on neural network
por: Li, Wei, et al.
Publicado: (2023)

Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Li, Na, et al.
Publicado: (2021)

Machine learning reveals two heterogeneous subtypes to assist immune therapy based on lipid metabolism in lung adenocarcinoma
por: Gu, Xuyu, et al.
Publicado: (2022)

Identification of pathological subtypes of early lung adenocarcinoma based on artificial intelligence parameters and CT signs
por: Fang, Weiyuan, et al.
Publicado: (2022)

Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma
por: Zhang, Wentao, et al.
Publicado: (2023)

A novel enterocyte-related 4-gene signature for predicting prognosis in colon adenocarcinoma
por: Cheng, Xuehua, et al.
Publicado: (2022)

Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma
por: Cui, Guoliang, et al.
Publicado: (2022)

Characterization of Two TNF-Related Subtypes Predicting Infliximab Therapy Responses in Crohn’s Disease
por: Ye, Chenglin, et al.
Publicado: (2022)

Development and validation of polyamines metabolism-associated gene signatures to predict prognosis and immunotherapy response in lung adenocarcinoma
por: Wang, Ning, et al.
Publicado: (2023)

The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma
por: Gao, Jingyan, et al.
Publicado: (2022)

Genomic analysis of TNF-related genes with prognosis and characterization of the tumor immune microenvironment in lung adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination
por: You, Weiqiang, et al.
Publicado: (2022)

Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis
por: Shu, Jianfeng, et al.
Publicado: (2023)

Cross-talk between cuproptosis and ferroptosis regulators defines the tumor microenvironment for the prediction of prognosis and therapies in lung adenocarcinoma
por: Shen, Yefeng, et al.
Publicado: (2023)

Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma
por: Zhao, Fangchao , et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Systematic Analysis and Identification of Molecular Subtypes of TRP-Related Genes and Prognosis Prediction in Lung Adenocarcinoma
por: Guo, Yang, et al.
Publicado: (2022)

A novel cuproptosis-related subtypes and gene signature associates with immunophenotype and predicts prognosis accurately in neuroblastoma
por: Tian, Xiao-Mao, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing
por: Yang, Jia, et al.
Publicado: (2023)

A Novel M6A-Related Genes Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Xuewen, et al.
Publicado: (2022)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

Vesicle-mediated transport-related genes are prognostic predictors and are associated with tumor immunity in lung adenocarcinoma
por: Qian, Changrui, et al.
Publicado: (2022)

The signature of cuproptosis-related immune genes predicts the tumor microenvironment and prognosis of prostate adenocarcinoma
por: Yao, Kai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0i5nu2oiefslbb0el3jqltd3u2